Baseline characteristics of patients enrolled in randomized controlled trials comparing combination therapy with angiotensin II receptor antagonists and ACE inhibitor therapy versus ACE inhibitor therapy alone in patients with congestive heart failure. This evidence concerns the gene ACE and congestive heart failure.